AORTF Stock UPDATES Aortech Internationa (AORTF) 0.5000 08/03/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Aortech Internationa (AORTF) 0.5000 $AORTF

Cardiovascular Devices - Europe Pipeline Product Analysis - Stage, Indication And Estimated Approval Date
M2 - Mon Jun 16, 6:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xdmzk9/cardiovascular) has announced the addition of the "Cardiovascular Devices - Europe Pipeline Product Analysis - Stage, Indication And Estimated Approval Date" report to their offering. This report consists of the entire process involved in making of a Cardiovascular Device. Right from Early Development stage through Pre-Clinical to Clinical trails and the Approval Process is also covered in this report. This report includes a total of 91 companies with 182 products in development. This report provides Pipeline Analysis of Cardiovascular devices developed by several medical device companies located in Europe. This report includes a detailed company profile for each medical device company operating in Europe. The company profile includes key company facts, information on business description, mission statement and its location. Moreover, this report provides detailed analysis of all pipeline products of each company with information on the product category, indication, development stage, estimated approval date and pipeline territory of the product. Cardiovascular Device areas covered in this report include: - Cardiac Assist Devices - Cardiovascular Monitoring and Diagnostic Devices - Cardiac Rhythm Management Devices - Cardiovascular Surgery Devices - Electrophysiology Devices - Interventional Cardiology Devices - Peripheral Vascular Devices Transcatheter Heart Valves Why buy the report? - Develop strategies for market entry and expansion. - Identify your competition's product portfolio and create effective strategies to gain competitive advantage. - Design and develop business strategies by understanding current trends and developments. - Identify the status and estimated approval of your competitor's pipeline products and develop your business strategies. Companies Mentioned: - AFreeze GmbH - AVIDAL Vascular GmbH - Aachen Resonance GmbH - Acarix A/S - Acrostak (Schweiz) AG - Aeon Scientific AG - Andramed GmbH - Anethon - AorTech International plc - Arterion AB - Arterius Ltd - B. Braun Melsungen AG - Bayer HealthCare AG - Berlin Heart GmbH - ICON plc - IRAMED GmbH - Imaxdi - Imaxdi. - Impulse Dynamics N.V. - Inserm Transfert SA - International Biomedical Systems S.p.A. - JenaValve Technology GmbH - Leman Cardiovascular - Leukocare AG - MaRVis Technologies GmbH - Maestro Heart SA - Microstim GmbH - iVascular S.L. - iiTech BV For more information visit http://www.researchandmarkets.com/research/xd...iovascular

Cardiovascular Devices - Europe Clinicals Pipeline Product Analysis
M2 - Mon Jun 16, 6:40AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bbc87m/cardiovascular) has announced the addition of the "Cardiovascular Devices - Europe Clinicals Pipeline Product Analysis" report to their offering. This report provides Pipeline Analysis of Clinical Cardiovascular devices developed by several medical device companies located in Europe. This report includes a total of 52 companies with 120 products in development. This report includes a detailed company profile for each medical device company operating in Europe. The company profile includes key company facts, information on business description, mission statement and its location. Moreover, this report provides detailed analysis on all pipeline products of each company with information on the product category, indication, development stage, estimated approval date and pipeline territory of the product. Cardiovascular Device areas covered in this report include: - Cardiac Assist Devices - Cardiovascular Monitoring and Diagnostic Devices - Cardiac Rhythm Management Devices - Cardiovascular Surgery Devices - Electrophysiology Devices - Interventional Cardiology Devices - Peripheral Vascular Devices - Transcatheter Heart Valves This report is built using data and information from in-house analysis by the team of industry experts at Mordor Intelligence and from primary & secondary research. Why buy the report? - Develop strategies for market entry and expansion. - Identify your competition's product portfolio and create effective strategies to gain competitive advantage. - Design and develop business strategies by understanding current trends and developments. - Identify the status and estimated approval of your competitor's pipeline products and develop your business strategies. Companies Mentioned: - AFreeze GmbH - AVIDAL Vascular GmbH - Aachen Resonance GmbH - Acrostak (Schweiz) AG - Andramed GmbH - AorTech International plc - Arterion AB - B. Braun Melsungen AG - Carmat SAS - CellProthera - Dipylon Medical AB - Eurocor GmbH - Evasc Medical Systems - HighLife SAS - I.B.S. S.p.A. - ICON plc - Imaxdi. - Impulse Dynamics N.V. - Qvanteq AG - SAS Cormove - Sorin S.p.A. - Stentys, S.A - Symetis AG - Tioga Ltd - Tissue Regenix Ltd - Transcatheter Technologies GmbH - TrusTECH For more information visit http://www.researchandmarkets.com/research/bb...iovascular

Transcatheter Heart Valve Market Outlook, 2013
M2 - Mon Jun 10, 3:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/3w68nx/transcatheter) has announced the addition of the "Transcatheter Heart Valve Market Outlook, 2013 - Approval of Second Generation Prosthetics and Increasing Surgeons' Confidence and Proficiency to Drive TAVR Procedure Volumes" report to their offering. Newcomer US to Dominate Global Transcatheter Heart Valve Market by 2017 Despite only entering the market in late 2011 with Edwards Lifesciences' Sapien, the US looks set to dominate the global Transcatheter Heart Valve (THV) market in the near future, according to business intelligence provider GBI Research. The firm's latest report* forecasts the number of Transcatheter Aortic Valve Replacement (TAVR) procedures in the US to climb from 7,946 in 2012 to 59,000 in 2017, driving the country's THV market from $238m to $1.9 billion during the same period. GBI Research states that, within one year, the US has managed to become the biggest country for THV sales, accounting for 28% of the glo

MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - European Markets
M2 - Mon Mar 11, 5:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8kfr86/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - European Markets" to their offering. This report is a vital source of up-to-date information with in-depth analysis on the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market in France, Germany, Italy, Spain and the UK (EU). Provided within is a comprehensive breakdown of opportunities and inhibitors within the major EU TAVR markets, highlighting testimonials from top physicians from around the world utilizing this technique already. The report identifies and analyzes the key trends shaping and driving the EU Transcatheter Aortic Valve Replacement Market. Future EU sales expectations are discussed through careful analysis of the Transcatheter Aortic Valve Replacement procedure adoption patterns. The report provides insight into the competitive TAVR landscape in the

MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - US Market
M2 - Mon Mar 11, 5:21AM CDT
Research and Markets (http://www.researchandmarkets.com/research/brtjc6/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast - US Market" to their offering. This report is a vital source of up-to-date information with in-depth analysis on the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market in the US. Provided within is a comprehensive breakdown of opportunities and inhibitors within the US TAVR market, highlighting testimonials from top physicians from around the world utilizing this technique already. The report identifies and analyzes the key trends shaping and driving the US Transcatheter Aortic Valve Replacement market. Future US sales expectations are discussed through careful analysis of the Transcatheter Aortic Valve Replacement procedure adoption patterns. The report provides insight into the competitive TAVR landscape in the US, including new companies entering the market and p

MediPoint: Transcatheter Aortic Valve Replacement - Current and Future Players
M2 - Thu Mar 07, 5:49AM CST
Research and Markets (http://www.researchandmarkets.com/research/7vv95q/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Current and Future Players" to their offering. This report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Transcatheter Aortic Valve Replacement (TAVR) Device Market. The report identifies and analyses the key companies shaping and driving the global Transcatheter Aortic Valve Replacement market. The report provides insight into the competitive TAVR landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by a team of industry experts. Scope - Investigation of current and future market competition for Transcatheter Aortic Valve Replacement, otherwise known as Transcatheter Aortic Valve Implantatio

MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast
M2 - Mon Feb 04, 8:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/94t355/medipoint) has announced the addition of GlobalData's new report "MediPoint: Transcatheter Aortic Valve Replacement - Analysis and Market Forecast" to their offering. New Aortic Valve Devices May Hold the Key to Your Heart Open heart surgery may be a dying art, as new valve replacement techniques offer life-changing treatment without the need for invasive procedures, states a new report by healthcare experts The authors. The new report* studies Transcatheter Aortic Valve Replacement (TAVR), which allows the percutaneous treatment of severe Aortic Valve Disease (AVD) through the implantation of a prosthetic aortic valve within the diseased native valve without the need for open heart surgery or cardiopulmonary bypass. Rob Littlefield, MSc., The authors's analyst for cardiovascular devices, states: "AVD affects over 3.6% of the population older than 65, and severe cases of it have mortality rates of nearly 50% at two years. However,



Scroll down for more posts ▼

Top 10 Most Recent News Articles

Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 9

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
Insta360 Tests Holiday Demand With $170 Gear Discounts

Updated Category News Views 161

A discount banner can reveal plenty about a hardware brand's priorities, and Insta360's latest Black Friday push is plainly built to put more of its ecosystem into customers' hands. The company is advertising savings of up to US$170 across cameras, gimbals, microphones, webcams, and accessories, with the promotion available for a limited time through its own store and...

Continue Reading
SciBase Sets Its 2027 AGM Nominating Committee Early

Updated Category News Views 34

Four names on a committee roster rarely make anyone pound the table, and they should not. Still, SciBase Holding has put an important bit of corporate housekeeping in place for its 2027 Annual General Meeting: the nominating committee that will handle shareholder-facing governance work ahead of the May 20 meeting in Stockholm. For a small listed medical-technology...

Continue Reading
MFB Bancorp Offering Puts Chicago Bank Conversion First

Updated Category News Views 23

A small Chicago thrift is asking investors to fund a corporate makeover, and the fine print matters more than the $10 sticker price. MFB Bancorp has commenced an offering tied to the planned conversion of Mutual Federal Bancorp, MHC from a mutual holding company structure into a stock holding company. This is not some high-growth bank story with a shiny new branch map. It...

Continue Reading
Everyday Dose Tests Coffee in a New Pocket Format Today

Updated Category News Views 22

Coffee has finally wandered into the candy aisle, and I cannot decide whether that is clever or mildly exhausting. Everyday Dose and Austin-based Le Lick have launched Le Latte, a limited-batch coffee-flavored electrolyte lollipop aimed at adults who want caffeine without hauling around a cup. It is an odd little product, sure, but odd is often where consumer brands find...

Continue Reading
Rox Taps Dynamics 365 Without Forcing a CRM Reset Yet

Updated Category News Views 89

Enterprise software buyers hate renovations when a useful extension will do. Rox’s new integration with Microsoft Dynamics 365 Sales, announced November 19, 2026, is built around that unglamorous but very real fact. The company is not asking a Global 2000 sales organization to rip out its customer system, retrain everybody, and pray an AI layer somehow pays for the...

Continue Reading
Scientific Games Takes Big Buck Hunter to Lotteries

Updated Category News Views 76

A mounted arcade cabinet is an odd place to find lottery growth, yet Scientific Games may be onto something with its exclusive Big Buck Hunter licensing deal. Announced November 19, 2026, the arrangement lets the company carry a 26-year-old arcade franchise into U.S. and Canadian instant scratch games, Fast Play, draw games, digital products and second-chance promotions....

Continue Reading
LiberNovo's European Black Friday Sale Tests Demand

Updated Category News Views 155

A €1,339 chair has no business pretending it is an impulse buy, which is exactly why LiberNovo’s Black Friday push deserves a closer look. The Hong Kong-based ergonomic-chair seller has rolled out its Black Friday sale across the European Union and United Kingdom, with the campaign ending November 30 at 23:59 CET in the EU and 23:59 GMT in the UK. This is a...

Continue Reading
Vail Resorts Bets on Music to Deepen Epic Pass Demand

Updated Category News Views 40

A bass drop at 11,000 feet is not merely a party trick when you run 42 mountain resorts. Vail Resorts is putting live music, après programming and destination events squarely beside skiing and riding for winter 2026-27, and the business logic is pretty plain: give people another reason to buy early, stay longer and return with friends. For investors watching MTN, this is...

Continue Reading
DoorDash Grocery Tools Need a Hard Look Before Checkout

Updated Category News Views 95

A grocery cart built in thirty seconds can still nick your wallet all week. That is the part buried beneath the convenience pitch around DoorDash's grocery tools: planning is useful, but convenience only earns its keep when the final basket, delivery charge, substitutions, and timing actually line up. The 2026 review from Expert Consumers highlights features that are...

Continue Reading

Top 5 Most Recently Viewed Articles

Jyske Realkredit A/S Announces New Bond Listing Details

Updated Category News Views 192

Key Announcement about New Bond Listings On August 20, Jyske Realkredit A/S is set to introduce new bonds to the market. This announcement signals a pivotal moment for investors and the financial community alike. The company is preparing to list a novel type of Covered Bond (SDO) and a Mortgage Bond (RO), which could have significant implications for the current market...

Continue Reading
Maze Therapeutics Engages Investors at Major BioConnect Event

Updated Category News Views 168

Maze Therapeutics Engages Investors at a Major Event Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company, is making waves in the healthcare industry with its innovative approach to developing small molecule precision medicines. Their focus on addressing renal, metabolic, and cardiovascular diseases underscores the company's commitment to...

Continue Reading
Iterum Therapeutics Successfully Completes $5 Million Offering

Updated Category News Views 161

Iterum Therapeutics Completes Significant Offering Iterum Therapeutics plc (NASDAQ: ITRM), a biopharmaceutical company dedicated to creating innovative solutions against multi-drug resistant pathogens, has officially announced the successful closure of its recent direct offering. This strategic fundraising effort resulted in the sale of 5,555,556 ordinary shares, or the...

Continue Reading
Shopify Achieves Unprecedented Milestone with $14.6 Billion Sales

Updated Category News Views 210

Shopify's Impressive Holiday Sales Growth Shopify Inc. (NASDAQ: SHOP) has recently announced a phenomenal achievement, showcasing that merchants on its platform generated a staggering $14.6 billion in sales during the holiday shopping weekend. This impressive figure marks a magnificent 27% increase compared to the previous year, with approximately 81 million customers...

Continue Reading
Hotel Okura and AWC Set to Launch Unique Ryokan Hotels

Updated Category News Views 305

Hotel Okura and AWC Announce New Ryokan-Style Hotels In an exciting development for Thailand's hospitality sector, Hotel Okura Co., Ltd., a leading global player in the Japanese hotel industry, has partnered with Asset World Corporation (AWC). This collaboration will bring two new ryokan-style hotels to Chiang Mai and Bangkok, both slated to open by the year 2028. This...

Continue Reading